Recordati claims potent and selective 5-HT1A receptor antagonists for urinary disorders March 12, 1999 No Comments
Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure Feb. 16, 1999 No Comments
RSS